Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer

NCT02413853 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study drug supply issues

Conditions

Colorectal Adenocarcinoma
Stage IVA Colorectal Cancer
Stage IVB Colorectal Cancer

Interventions

DRUG: CBP/beta-catenin Antagonist PRI-724
BIOLOGICAL: Bevacizumab
DRUG: Leucovorin Calcium
DRUG: Oxaliplatin
DRUG: Fluorouracil
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]